Sen. Sheldon Whitehouse sold Regeneron Pharmaceuticals (REGN)
Sen. Sheldon Whitehouse (D-RI) · $15K–$50K · traded Dec 18, 2017
- Transaction
- Sold (full)
- Amount
- $15K–$50K
- Owner
- The member
- Traded
- Dec 18, 2017
- Disclosed
- Jan 10, 2018
- Days to disclose
- 23
- Asset type
- Stock
- As filed
- Regeneron Pharmaceuticals, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Jan 10, 2018$1K–$15K
$1K–$15K · Traded Dec 18, 2017 · disclosed Jan 10, 2018 · Joint
- Jan 10, 2018$15K–$50K
Sold (full) Johnson Controls International JCI
$15K–$50K · Traded Dec 5, 2017 · disclosed Jan 10, 2018
- Jan 10, 2018$1K–$15K
$1K–$15K · Traded Dec 5, 2017 · disclosed Jan 10, 2018
- Jan 10, 2018$1K–$15K
$1K–$15K · Traded Dec 5, 2017 · disclosed Jan 10, 2018
Recent Congress trades in REGN
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Regeneron Pharmaceuticals REGN
$1K–$15K · Traded May 15, 2026 · disclosed Jun 8, 2026
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Mar 12, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Feb 12, 2026 · disclosed Mar 12, 2026
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Nov 18, 2025 · disclosed Dec 15, 2025
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
Company context for REGN
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
REGN: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
REGN: Financial results
Filed 8-K for an event or period dated 2026-10-30. Financial results.
REGN: Material agreement · Financial results · Other company developments
Filed 8-K for an event or period dated 2026-10-01. Material agreement; Financial results; Other company developments.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.